Philip Seeman

Philip Seeman (born February 8 1934) is a Canadian schizophrenia researcher and neuropharmacologist, known for his research on dopamine receptors.

Additional recommended knowledge

Daily Sensitivity Test

Don't let static charges disrupt your weighing accuracy

Essential Laboratory Skills Guide

Born in Winnipeg, Manitoba, he was raised in Montreal. He received a Bachelor of Science degree, honours Physics & Physiology (1955), a Master of Science degree, Physiology of Transport & Secretion (1956), and a Doctor of Medicine (1960) from McGill University. In 1966, he received a Ph.D. in Life Sciences from Rockefeller University.

In 1967, he became an Assistant Professor in the Department of Pharmacology at the University of Toronto. In 1970, he was appointed a Professor.

In 1974, having spent years in search for the binging site of antipsychotic medication, he discovered the dopamine D2 receptor.^[1]

In 2001, he was made an Officer of the Order of Canada "for his research on dopamine receptors and their involvement in diseases such as schizophrenia, Parkinson's and Huntington's". [1] In 1985, he was made a Fellow of the Royal Society of Canada.

References